Prospective replication study implicates the catechol-O-methyltransferase Val(158)Met polymorphism as a biomarker for the response to morphine in patients with cancer

Genetic differences in humans cause clinical difficulties in opioid treatment. Previous studies indicate that a single nucleotide polymorphism in the catechol-O-methyltransferase (COMT) gene (rs4680; p.Val(158)Met) may present as a predictive biomarker for the response to morphine treatment. In our...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomed Rep
Main Authors: Matsuoka, Hiromichi, Makimura, Chihiro, Koyama, Atsuko, Fujita, Yoshihiko, Tsurutani, Junji, Sakai, Kiyohiro, Sakamoto, Ryo, Nishio, Kazuto, Nakagawa, Kazuhiko
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5590034/
https://ncbi.nlm.nih.gov/pubmed/28928973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2017.963
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados